The University of North Carolina at Chapel Hill
Skip to main content
UNC School of Medicine

Category: Infectious Diseases

  • Doctors Provide Up-Close View of Pandemic in Area Hospitals, Guidance On Limiting Viral Spread

    David Wohl, MD, talked about the pandemic with other infectious disease experts on WRAL. Infectious disease experts David Wohl, MD, Cameron Wolfe, MBBS (Duke University Health), and Chris DeRienzo, MD, MPP (WakeMed), discuss what they’re seeing at area hospitals during the pandemic and ways to slow the surge in new coronavirus infections. See this 30-minute round-table Zoom discu … Read more

  • david-wohl-tarheel-of-the-month

    Wohl Named Tar Heel of the Month

    David Wohl, MD (credit: Mark Derewicz) For his years of work studying infectious diseases and his role in helping North Carolina health professionals and residents respond to the pandemic, David Wohl, MD, is the News & Observer’s November Tar Heel of the Month, which honors people who have made significant contributions to North Carolina and the region.  Read the story in the … Read more

  • Wohl Honored With First Charles Van Der Horst Humanitarian Award

    David Wohl, left, takes a break while cycling with his former colleague and mentor, Charlie van der Horst (credit: UNC IGHID) The national AIDS Clinical Trials Group expanded its annual recognition program in 2020 with two new awards named for University of North Carolina faculty members who died in 2019: Charles van der Horst, MD, an infectious diseases physician and researcher, … Read more

  • Joe Eron, MD

    More COVID-19 Vaccine Options Could Aid Distribution Timeline, Especially in Rural Areas

    Joe Eron, MD News of Oxford University and AstraZeneca’s successful COVID-19 vaccine trial is inspiring increased optimism within the medical community. “We need billions of doses. And different vaccines have different upsides and downsides. Like the newest one we heard about yesterday, AstraZeneca. It’s easier to manufacture. So there (are) more doses that can be made, and proba … Read more

  • joe-eron

    Third Major Coronavirus Vaccine Shown To Be Effective and Cheaper

    Joseph Eron, MD An Associated Press article reports the “drugmaker AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine is highly effective, buoying the prospects of a relatively cheap, easy-to-store product that may become the vaccine of choice for the developing world.” Joe Eron, MD, chief of the division of infectious diseases, said that it is unclear … Read more

  • David Weber, MD, MPH

    COVID-19 Vaccines Are Coming. How Will NC Roll Out Doses, and Will People Accept Them?

    David Weber, MD, MPH From Governor Roy Cooper to infectious disease experts to ordinary residents, North Carolinians are thrilled by the prospects of two COVID-19 vaccines currently under trial with the U.S. Food and Drug Administration. “None of us can predict how many people will actually want the vaccine given people’s concerns for a variety of reasons,” said David Weber, MD, … Read more

  • CindyGay-newsworthy-nov-2021

    Moderna’s Initial Vaccine Results ‘More Than Hoped For,’ Says Gay

    Cindy Gay, MD, MPH Cindy Gay, MD, MPH, associate professor of medicine in the division of infectious diseases, oversees the clinical trial of Moderna’s coronavirus vaccine candidate at UNC-Chapel Hill. She says the high initial efficacy rate shown by the drug “was more than we were hoping for.” Listen to her interview with WRAL News.

  • Sidney Smith, MD, and Myron Cohen, MD

    Smith, Cohen Recognized in Clarivate’s 2020 list of Highly Cited Researchers

    Sidney Smith, MD, and Myron Cohen, MD Sidney Smith, MD, and Myron Cohen, MD, have been recognized in Clarivate’s 2020 list of Highly Cited Researchers™.  Altogether the list includes 20 UNC School of Medicine and 16 UNC Chapel Hill researchers who have demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during … Read more

  • emily-sickbert-cbs-17-wearing-a-mask

    Sickbert-Bennett Featured in UNC Health Media Briefing About COVID Precautions During the Holidays

    Emily Sickbert-Bennett, PhD, assistant professor in infectious diseases and medical director of UNC Medical Center Infection Prevention, participated in the UNC Health Media Briefing “COVID Precautions During the Holidays.”

  • emily-sickbert-cbs-17-wearing-a-mask

    Coronavirus Today – Nov. 12 COVID Spread in Rural NC; Testing For Holiday Travelers and College Students; Insurance and Travel Testing

    Emily Sickbert-Bennett, PhD, MS As North Carolina’s COVID-19 case counts rise steadily, the tightening grip of the coronavirus is having a disparate impact on the state’s rural counties. In a North Carolina Health News report, Emily Sickbert-Bennett, PhD, associate professor of infectious diseases, told reporters college students could begin preparing for visits home now by isola … Read more

  • parr-fischer-nyt-article

    An Explanation For Some Covid-19 Deaths May Not Be Holding Up

    Early in the pandemic, anti-il-6 drugs became a standard of care for treating COVID patients at many hospitals, widely believed to quell the immune system response. Now, evidence mounts that they are not effective. Jonathan Parr, MD, MPH, in infectious diseases, and William Fischer, MD, in pulmonary medicine, were interviewed by the New York Times.

  • Myron Cohen, MD-ID-faculty-in-covid-news-dec-24-30

    ‘Major advance’: Long-acting injectable more effective than daily pill in preventing HIV

    A long-acting injectable drug, cabotegravir, is safe and more effective than a daily pill in preventing HIV acquisition, according to results from a study of 3,127 cisgender women in sub-Saharan Africa. “New HIV prevention agents that address the many needs of all individuals at risk for acquiring HIV are essential pillars of our strategy to end the HIV epidemic,” says Myron Cohe … Read more